Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy.

Pagani FD, Aaronson KD, Kormos R, Mann DL, Spino C, Jeffries N, Taddei-Peters WC, Mancini DM, McNamara DM, Grady KL, Gorcsan J 3rd, Petrucci R, Anderson AS, Glick HA, Acker MA, Eduardo Rame J, Goldstein DJ, Pamboukian SV, Miller MA, Timothy Baldwin J; REVIVE-IT Investigators.

J Heart Lung Transplant. 2016 Nov;35(11):1277-1283. doi: 10.1016/j.healun.2016.09.002. Epub 2016 Oct 6.

PMID:
27836022
2.

A hybrid effectiveness-implementation cluster randomized trial of group CBT for anxiety in urban schools: rationale, design, and methods.

Eiraldi R, Khanna MS, Jawad AF, Fishman J, Glick HA, Schwartz BS, Cacia J, Wandersman A, Beidas R.

Implement Sci. 2016 Jul 12;11:92. doi: 10.1186/s13012-016-0453-z.

3.

Impact of intensive lifestyle intervention on preference-based quality of life in type 2 diabetes: Results from the Look AHEAD trial.

Zhang P, Hire D, Espeland MA, Knowler WC, Thomas S, Tsai AG, Glick HA; Look AHEAD Research Group.

Obesity (Silver Spring). 2016 Apr;24(4):856-64. doi: 10.1002/oby.21445. Epub 2016 Mar 8.

4.

The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.

Glick HA, Li P, Harvey PD.

Schizophr Res. 2015 Aug;166(1-3):110-4. doi: 10.1016/j.schres.2015.05.021. Epub 2015 Jun 2.

PMID:
26044113
5.

Comparative effectiveness and cost-effectiveness analyses frequently agree on value.

Glick HA, McElligott S, Pauly MV, Willke RJ, Bergquist H, Doshi J, Fleisher LA, Kinosian B, Perfetto E, Polsky DE, Schwartz JS.

Health Aff (Millwood). 2015 May;34(5):805-11. doi: 10.1377/hlthaff.2014.0552.

PMID:
25941282
6.

Low Health Literacy Predicts Misperceptions of Diabetes Control in Patients With Persistently Elevated A1C.

Ferguson MO, Long JA, Zhu J, Small DS, Lawson B, Glick HA, Schapira MM.

Diabetes Educ. 2015 Jun;41(3):309-19. doi: 10.1177/0145721715572446. Epub 2015 Feb 19.

PMID:
25699568
7.

Re-examining the BMI threshold for bariatric surgery in the USA.

Choudhury RA, Murayama KM, Neylan CJ, Savulionyte G, Glick HA, Williams NN, Dempsey DT, Dumon KR.

J Gastrointest Surg. 2014 Dec;18(12):2074-9. doi: 10.1007/s11605-014-2653-7. Epub 2014 Oct 9.

PMID:
25297444
8.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

9.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators.

N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.

10.

Roux-en-Y gastric bypass compared with aggressive diet and exercise therapy for morbidly obese patients awaiting renal transplant: a decision analysis.

Choudhury RA, Murayama KM, Abt PL, Glick HA, Naji A, Williams NN, Dumon KR.

Surg Obes Relat Dis. 2014 Jan-Feb;10(1):79-87. doi: 10.1016/j.soard.2013.04.016. Epub 2013 May 23.

PMID:
24139923
11.

Cost-effectiveness of a primary care intervention to treat obesity.

Tsai AG, Wadden TA, Volger S, Sarwer DB, Vetter M, Kumanyika S, Berkowitz RI, Diewald LK, Perez J, Lavenberg J, Panigrahi ER, Glick HA.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S31-7. doi: 10.1038/ijo.2013.94.

12.

Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study.

Margolis DJ, Gupta J, Hoffstad O, Papdopoulos M, Glick HA, Thom SR, Mitra N.

Diabetes Care. 2013 Jul;36(7):1961-6. doi: 10.2337/dc12-2160. Epub 2013 Feb 19.

13.

Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.

Dewitt EM, Li Y, Curtis JR, Glick HA, Greenberg JD, Anstrom KJ, Kremer JM, Reed G, Schulman KA, Reed SD.

J Rheumatol. 2013 Feb;40(2):127-36. doi: 10.3899/jrheum.120400. Epub 2013 Jan 15.

PMID:
23322461
14.

Clinical effectiveness, access to, and satisfaction with care using a telehomecare substitution intervention: a randomized controlled trial.

Bowles KH, Hanlon AL, Glick HA, Naylor MD, O'Connor M, Riegel B, Shih NW, Weiner MG.

Int J Telemed Appl. 2011;2011:540138. doi: 10.1155/2011/540138. Epub 2011 Dec 1.

15.

Sample size and power for cost-effectiveness analysis (Part 2): the effect of maximum willingness to pay.

Glick HA.

Pharmacoeconomics. 2011 Apr;29(4):287-96. doi: 10.2165/11585080-000000000-00000.

PMID:
21395349
16.

Sample size and power for cost-effectiveness analysis (part 1).

Glick HA.

Pharmacoeconomics. 2011 Mar;29(3):189-98. doi: 10.2165/11585070-000000000-00000.

PMID:
21309615
17.

Estimation and validation of a multiattribute model of Alzheimer disease progression.

Stallard E, Kinosian B, Zbrozek AS, Yashin AI, Glick HA, Stern Y.

Med Decis Making. 2010 Nov-Dec;30(6):625-38. doi: 10.1177/0272989X10363479.

18.

What do international pharmacoeconomic guidelines say about economic data transferability?

Barbieri M, Drummond M, Rutten F, Cook J, Glick HA, Lis J, Reed SD, Sculpher M, Severens JL; ISPOR Good Research Practices Economic Data Transferability Task Force.

Value Health. 2010 Dec;13(8):1028-37. doi: 10.1111/j.1524-4733.2010.00771.x.

19.

Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial.

Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE.

Addiction. 2010 Sep;105(9):1616-24. doi: 10.1111/j.1360-0443.2010.03001.x. Epub 2010 Jul 12.

20.

Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.

Tsai AG, Williamson DF, Glick HA.

Obes Rev. 2011 Jan;12(1):50-61. doi: 10.1111/j.1467-789X.2009.00708.x. Review.

Supplemental Content

Loading ...
Support Center